GlassScriptPhysician profile
Carol J Adams
NPI 1558346379
$816.72
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $169 · 2021: $335 · 2023: $44.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $44.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $44.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $141.64 | 2019-2021 | |
| Daiichi Sankyo INC. | $93.59 | 2019-2021 | |
| Therapeuticsmd, INC. | $76.83 | 2019-2021 | |
| Exeltis, USA INC. | $66.19 | 2020-2021 | |
| Roche Diagnostics Corporation | $54.24 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.35 | 2019-2021 | |
| Avion Pharmaceuticals | $52.65 | 2019-2021 | |
| Astellas Pharma US INC | $52.40 | 2021 | |
| Abbott Laboratories | $44.93 | 2023 | Freestyle Libre 2 |
| Allergan, INC. | $34.75 | 2019 | |
| Myovant Sciences INC. | $33.69 | 2021 | |
| Evofem Biosciences, INC. | $26.51 | 2020-2021 | |
| Helsinn Therapeutics (U.S.), INC. | $17.09 | 2019 | |
| Coopersurgical, INC. | $15.67 | 2021 | |
| Lupin INC. | $14.99 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $14.50 | 2020 | |
| Merck Sharp & Dohme LLC | $12.08 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.